Analysis of Cisatracurium Consumption in Balanced Anesthesia With 1% Sevoflurane, and With Only Sevoflurane, Using a Closed-loop Computer Controlled System Infusion.
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 156
- Locations
- 1
- Primary Endpoint
- Cisatracurium consumption rate.
Study Overview
Brief Summary
The aim in this study was to quantify the difference in cisatracurium and sufentanil consumption, and its recovery period, when patients are under balanced general anesthesia with 1% sevoflurane and patients under only sevoflurane general anesthesia, using a closed loop computer control infusion. Investigators further investigated this effect on its recovery period and sufentanyl consumption.
Detailed Description
156 patients of American Society of Anesthesiologists (ASA) physical status I and II were assigned to three groups. The patients were all on schedule for elective general surgery under general anesthesia with duration of at two to four hours. All patients were induced with Etomidate (0.2mg/kg), Midazolam (0.05-0.1mg/kg), Sufentanil (0.3-0.5µg/kg) and a bolus dose of Cisatracurium (0.15mg/kg). Patients were aged between 20 and 65. The maintenance of anesthesia in each group varies as follows: Patients in Group 1 were all maintained with Total Intravenous Anesthesia, Group 2 with Sevoflurane at 1% and propofol infusion, Group 3 with only sevoflurane. Muscle paralysis is maintained using a closed-loop computer gated infusion of Cisatracurium which kept T1 <1% by giving increasing the infusion rate intra-operatively when required. Analgesia was maintained by intermittent bolus dose of 10-20 µg of Sufentanil.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Basic Science
- Masking
- None
Eligibility Criteria
- Ages
- 20 Years to 65 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Patients aged 20 and
- •Patients with ASA 1 and
- •Patients for elective abdominal general surgery
Exclusion Criteria
- •Patients with the following diseases are excluded, since they are known to cause generalized neuromuscular weakness:
- •Neuromuscular junction disorders (e.g.. myasthenia gravis) Myopathies (e.g.. Muscular Dystrophies, Rhabdomyolysis) Peripheral Neuropathies (e.g. Guillain-Barre Syndrome, Polyneuropathies) Encephalopathies (Septic and Toxic-metabolic Encephalopathy) Patients with renal and liver diseases.
- •Patients who are sent intubated to ICU after surgery.
- •Patients refusal
Arms & Interventions
Total Intravenous Anesthesia
Only propofol infusion is used for maintenance of anesthesia keeping Bispectral Index (BIS) between 45-55.
Intervention: Propofol (Drug)
1% Sevoflurane
1% Sevoflurane with propofol infusion is used for maintenance. BIS is kept between 45-55 by adjusting propofol infusion.
Intervention: 1% Sevoflurane (Drug)
Sevoflurane
Only Sevoflurane is used for maintenance keeping BIS between 45-55
Intervention: Sevoflurane (Drug)
Outcomes
Primary Outcomes
Cisatracurium consumption rate.
Time Frame: At the time of surgery.
Measurements were done intraoperatively. Investigators obtained data from the closed loop computer system, from which the intra-operative consumption of cisatracurium were obtained from each patient. Data were collected only during surgery. Each patient had different cisatracurium consumption rate, and the mean consumption rate of the patients within the same group were calculated, and compared with the means from the other groups.
Secondary Outcomes
- Analysis of Means of Recovery Index.(30 minutes post operative.)
Investigators
Joomye Shehzaad
Joomye Shehzaad M.D.
Tianjin Medical University General Hospital